APOA1 and metabolic syndrome: Our results for the first time indicated that moderate dyslipidemia and dyslipoproteinemia caused chronic inflammation in artery wall and slowly increased the concentration of MPO, inflammatory markers and MPO/apoAI, MPO/HDL-C ratios and together gradually deterioration of dyslipidemia and dyslipoproteinemia.